Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization

Tadaaki Arizumi, Tomohiro Minami, Masashi Kono, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Yasunori Minami, Toshiharu Sakurai, Kazuomi Ueshima, Naoshi Nishida and Masatoshi Kudo
Additional contact information
Masatoshi Kudo: Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan

Biomedical Journal of Scientific & Technical Research, 2019, vol. 14, issue 5, 1-5

Abstract: Transcatheter arterial chemoembolization (TACE) refractoriness is an indication for sorafenib treatment in patients with intermediate-stage hepatocellular carcinoma (HCC)...

Keywords: Biomedical Sciences; Biomedical Research; Technical Research; Hepatocellular carcinoma; Intermediate stage; Sorafenib; TACE refractoriness (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.002610.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.002610.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:14:y:2019:i:5:p:1-5

DOI: 10.26717/BJSTR.2019.14.002610

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().